XML 26 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stock-based Compensation
3 Months Ended
Mar. 31, 2024
Stock-based Compensation [Abstract]  
Stock-Based Compensation
NOTE 8 – Stock-based Compensation


Prior to June 21, 2023, the Company issued stock-based compensation awards to its directors and officers under the 2018 Long Term Incentive Plan (“LTIP”) which allowed the grant of non-qualified and incentive stock options, stock appreciation rights, full value awards and cash incentive awards.  The maximum number of shares available to be awarded under the LTIP was 161,638 shares.


During February of 2023, the Company issued 9,230 shares of stock to its directors under the LTIP, which were fully vested.  During the three months ended March 31, 2024 and 2023, the Company recorded $0 and $96 thousand of director stock compensation expense, respectively, which was determined using the fair value of the stock on the dates of the awards.


During March of 2022, the Company issued 61,907 shares of restricted stock to its officers and employees under the LTIP, of which 17,012 shares have been forfeited as of March 31, 2024. Each restricted stock award was valued based on the fair value of the stock on the date of the award. These awarded shares of restricted stock fully vest over periods ranging from 36 months to 60 months from their respective dates of grant.


On June 21, 2023, stockholders approved an Amendment and Restatement of the 2018 Long Term Incentive Plan (“Amended and Restated LTIP”) which allows the issuance of 487,500 additional shares and brought the number of shares that may be issued under the Amended and Restated LTIP to 649,138 shares.



On June 21, 2023, the Company issued 92,700 shares of restricted stock to its officers and employees under the Amended and Restated LTIP, of which 11,237 shares have been forfeited as of March 31, 2024. Each restricted stock award was valued based on the fair value of the stock on the date of the award. These awarded shares of restricted stock fully vest over periods ranging from 36 months to 60 months from their respective dates of grant.


On March 26, 2024, the Company issued 94,413 shares of restricted stock to its officers and employees under the Amended and Restated LTIP. Each restricted stock award was valued based on the fair value of the stock on the date of the award. These awarded shares of restricted stock fully vest over periods ranging from 36 months to 60 months from their respective dates of grant.


Stock-based compensation is recognized on a straight-line basis over the vesting period. During the three months ended March 31, 2024 and 2023, the Company recorded $77 thousand and $38 thousand of stock-based compensation expense, respectively.


As of March 31, 2024, 293,681 shares had been awarded under the Amended and Restated LTIP and 355,458 shares were available to be awarded.

No stock options were granted, exercised, forfeited or expired during the three months ended March 31, 2024 or the three months ended March 31, 2023.


Options outstanding and exercisable at March 31, 2024 were as follows:

Outstanding
   
Exercisable
 
Number
Outstanding
 
Weighted Average
Remaining
Contractual Life
 
Weighted
Average
Exercise Price
   
Aggregate
Intrinsic
Value
   
Number
Outstanding
   
Weighted
Average
Exercise Price
   
Aggregate
Intrinsic Value
 
 
31,250
 
1.88 years
 
$
12.96
   
$
     
31,250
   
$
12.96
   
$
 



The Company did not record any stock-based compensation expense related to stock options during the three months ended March 31, 2024 and 2023.



All common stock share amounts above have been retroactively adjusted, as applicable, for the 1-for-8 reverse stock split effective November 1, 2023.  See Note 1.